![Alexander Calatzis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexander Calatzis
Chief Executive Officer at Dynabyte - Informationssysteme GmbH
Network origin in Alexander Calatzis first degree
Entity | Entity type | Industry | |
---|---|---|---|
Dynabyte - Informationssysteme GmbH
![]() Dynabyte - Informationssysteme GmbH Miscellaneous Commercial ServicesCommercial Services Dynabyte - Informationssysteme GmbH is a German company that provides drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets. The private company is based in Munich, Germany. The company has a team of over 510 specialists who are industry-leading experts in key markets. The company's expertise is trusted in Pharma Intelligence. The company offers extensive coverage of medtech news and insights, trends, and source information on the impact of technologies like diagnostic imaging. The company was founded in 1986, and the CEOs are Andreas Calatzis and Alexander Calatzis.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alexander Calatzis via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
enicor GmbH
![]() enicor GmbH Medical SpecialtiesHealth Technology enicor GmbH engages development, production, and marketing of medical technology solutions. The firm distributes its products under the ClotPro analyzer, Active Tip Technology, and ClotPro controls brands. It also offers coagulation assays, cups and pins, as well as software solutions. The company was founded by Andreas Calatzis on March 4, 2019 and is headquartered in Munich, Germany. | Medical Specialties | Chief Executive Officer | |
GlyCardial Diagnostics SL
![]() GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Miscellaneous Commercial Services | Chairman |
Statistics
International
Germany | 2 |
Spain | 2 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Operational
Chief Executive Officer | 2 |
Founder | 1 |
Chairman | 1 |
Most connected contacts
Insiders | |
---|---|
Andreas Calatzis | 3 |
- Stock Market
- Insiders
- Alexander Calatzis
- Company connections